Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

88
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
88
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

37
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

513
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
513
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

81
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
81
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

60
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinal Microvascular Disease in Diabetes and Its Prognostic Utility for Cardiovascular and Renal Complications: A Comprehensive Literature Review.

Cureus·2026
Same author

Cognitive Decline in Chronic Inflammatory Conditions: Exploring Links Between Systemic Inflammation and Neurodegeneration.

Cureus·2025
Same author

Timing and Protocols for Microbiome Intervention in Surgical Patients: A Literature Review of Current Evidence.

Cureus·2025
Same author

Robot-Assisted Surgery: Current Applications and Future Trends in General Surgery.

Cureus·2025

Related Experiment Video

Updated: Sep 15, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.9K

Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology and Integrated Management Approach.

Carlos Alejandro Arragan Lezama1, Julio Joel Jaramillo Ramos2, David Alejandro Armas Eguizábal3

  • 1General Practice, Universidad Anáhuac Xalapa, Veracruz, MEX.

Cureus
|July 15, 2025
PubMed
Summary

Heart, kidney, liver, and metabolic diseases share common pathways like inflammation. Integrated care is complex, but lifestyle changes and early interventions can break the cycle of organ damage.

Keywords:
advanced therapiescardiovascular renal hepatic metabolic syndromecrhm syndromeemerging therapiesintegrated management approach

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K
An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
10:31

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment

Published on: April 20, 2018

10.8K

Related Experiment Videos

Last Updated: Sep 15, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.9K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K
An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
10:31

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment

Published on: April 20, 2018

10.8K

Area of Science:

  • Multisystemic disease mechanisms
  • Cardiovascular-renal-hepatic-metabolic (CRHM) syndrome research

Background:

  • Heart, kidney, liver, and metabolic diseases share common pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial dysfunction.
  • Integrated care for these interconnected conditions is challenging due to disparate symptoms, diagnostic criteria, and treatment protocols.

Purpose of the Study:

  • To investigate the shared mechanisms underlying the cardiovascular-renal-hepatic-metabolic syndrome.
  • To explore strategies for coordinating the management of these interrelated diseases.

Main Methods:

  • Review of interdisciplinary research on shared pathological pathways.
  • Analysis of factors contributing to the vicious cycle of organ damage.
  • Examination of clinical practice barriers and potential interventions.

Main Results:

  • Dysfunction in the gut-organ axis and inflammation are significant contributors to multiple organ diseases.
  • A vicious cycle of damage exacerbates hypertension, chronic kidney disease, non-alcoholic fatty liver disease, and metabolic syndrome.
  • Interventions in medicine, lifestyle, and pharmacotherapy can disrupt pathological cascades.

Conclusions:

  • Coordinated management of CRHM syndrome is crucial for preventing progressive organ damage.
  • Early risk assessment and intervention, alongside lifestyle modifications, are key to interrupting disease progression.
  • Addressing gut-organ axis dysfunction and inflammation is vital for comprehensive patient care.